Zafirlukast



Indications and Reactions:

Role Indications Reactions
Primary
Asthma 47.1%
Nasal Polyps 11.8%
Eosinophilia 5.9%
Rhinitis 5.9%
Capsular Contracture Associated With Breast Implant 2.9%
Chronic Obstructive Pulmonary Disease 2.9%
Depression 2.9%
Epilepsy 2.9%
Gastrooesophageal Reflux Disease 2.9%
Muscle Contractions Involuntary 2.9%
Nausea 2.9%
Rheumatoid Arthritis 2.9%
Seasonal Allergy 2.9%
Type 2 Diabetes Mellitus 2.9%
Off Label Use 15.8%
Polyuria 10.5%
Product Substitution Issue 10.5%
Weight Decreased 10.5%
Alopecia 5.3%
Dysphonia 5.3%
Dyspnoea 5.3%
Intentional Drug Misuse 5.3%
Multiple Allergies 5.3%
Nausea 5.3%
Pancytopenia 5.3%
Throat Irritation 5.3%
Thrombocytopenia 5.3%
Warm Type Haemolytic Anaemia 5.3%
Secondary
Drug Use For Unknown Indication 29.7%
Asthma 28.7%
Product Used For Unknown Indication 10.9%
Multiple Allergies 8.9%
Bronchitis 5.9%
Chronic Obstructive Pulmonary Disease 5.9%
Analgesic Asthma Syndrome 5.0%
Eosinophilia 2.0%
Dry Eye 1.0%
Eye Disorder 1.0%
Gastrooesophageal Reflux Disease 1.0%
Wheezing 24.0%
Completed Suicide 16.0%
Weight Decreased 16.0%
Polyuria 8.0%
Anaemia Haemolytic Autoimmune 4.0%
Arthritis 4.0%
Death 4.0%
Drug Ineffective 4.0%
Drug Toxicity 4.0%
Hyponatraemia 4.0%
Intentional Drug Misuse 4.0%
Mononeuritis 4.0%
Weight Increased 4.0%
Concomitant
Drug Use For Unknown Indication 43.8%
Asthma 16.9%
Product Used For Unknown Indication 12.5%
Ill-defined Disorder 6.5%
Hypertension 2.7%
Gastrooesophageal Reflux Disease 2.3%
Crohn's Disease 2.1%
Arthralgia 2.0%
Rheumatoid Arthritis 1.4%
Psoriatic Arthropathy 1.1%
Back Disorder 0.9%
Bronchitis 0.9%
Cardiac Disorder 0.9%
Cellulitis 0.9%
Chronic Obstructive Pulmonary Disease 0.9%
Depression 0.9%
Diabetes Mellitus 0.9%
Dyspnoea 0.9%
Type 2 Diabetes Mellitus 0.8%
Arthritis 0.6%
Transient Ischaemic Attack 11.7%
Asthma 10.0%
Hypersensitivity 8.3%
Rash 8.3%
Chronic Obstructive Pulmonary Disease 5.0%
Fistula 5.0%
Stress 5.0%
Syncope 5.0%
Wheezing 5.0%
Cardiac Disorder 3.3%
Diarrhoea 3.3%
Insomnia 3.3%
Liver Function Test Abnormal 3.3%
Nausea 3.3%
Pain 3.3%
Pancreatitis Acute 3.3%
Sensory Loss 3.3%
Sinusitis 3.3%
Swelling 3.3%
Viral Upper Respiratory Tract Infection 3.3%
Interacting
Drug Use For Unknown Indication 50.0%
Bronchitis 25.0%
Rhinitis 25.0%
Drug Interaction 100.0%